Details of the Drug

General Information of Drug (ID: DMO1QX4)

• Drug Name: Sodium Succinate
• Synonyms: Disodium succinate; SODIUM SUCCINATE; 150-90-3; Disodium butanedioate; Butanedioic acid, disodium salt; Succinic acid disodium salt; Soduxin; Jantaran sodny [Czech]; UNII-V8ZGC8ISR3; Succinic acid, disodium salt; FEMA No. 3277; CCRIS 3700; Sodium succinate dibasic; EINECS 205-778-7; V8ZGC8ISR3; Butanedioic acid, sodium salt (1:2); Succinic acid disodium salt anhydrous; Butanedioic acid disodium salt; sodium succinate (anhydrous); Jantaran sodny; Butanedioic acid disodium hexahydrate; Succinic acid, disodium salt, 99%, anhydrous

Indication

Disease Entry	ICD 11	Status	REF
Arthritis	FA20	Approved	[1]

• Drug Type: Small molecular drug
• Chemical Identifiers:
  Formula: C4H4Na2O4
  Canonical SMILES: C(CC(=O)[O-])C(=O)[O-].[Na+].[Na+]
  InChI: InChI=1S/C4H6O4.2Na/c5-3(6)1-2-4(7)8;;/h1-2H2,(H,5,6)(H,7,8);;/q;2*+1/p-2
  InChIKey: ZDQYSKICYIVCPN-UHFFFAOYSA-L
• Cross-matching ID:
  PubChem CID: 9020
  ChEBI ID: CHEMBL63675
  CAS Number: 150-90-3
  TTD ID: D03RCJ
• Drug ADMET Endpoint Profile (DAE)NEW: Click to Jump to the Detailed DAE Information of This Drug

References

• [1] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015